Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 1

Assesment of serum alkaline phosphatase levels on the risk of presence hepatocelluler carcinoma in the liver transplantation patients

Pages
194–198
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Follow-up studies are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Multivarious serum biomarkers have been investigated for their potential prognostic value in HCC.
📊
Key Findings & Data:This aim of study evaluatethe effects of Alkaline phosphatase levels on the risk of presence Hepathocelluler canser (HCC) among the liver transplantationpatients.Material and Methods: Between 2004 and 2018 878 consecutive adult Liver Tranplantation patients in our center was reviewedThese patients were divided into two groups according to presence of HCC [(n=208) HCC positive (Group A) and (n=670) HCCnegative (Group B)].Data collection included, We evaluated the predictive values of liver fonctions tested liver enzymes (alanineaminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase [ALP], and gamma-glutamyltransferase [GGT],Hemoglobine (Hb), international normalized ratio (INR).
💡
Conclusion & Impact:Follow-up studies are needed.
🔬Design:Review & Systematic Survey
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Multivarious serum biomarkers have been investigated for their potential prognostic value in HCC. This aim of study evaluatethe effects of Alkaline phosphatase levels on the risk of presence Hepathocelluler canser (HCC) among the liver transplantationpatients.Material and Methods: Between 2004 and 2018 878 consecutive adult Liver Tranplantation patients in our center was reviewedThese patients were divided into two groups according to presence of HCC [(n=208) HCC positive (Group A) and (n=670) HCCnegative (Group B)].Data collection included, We evaluated the predictive values of liver fonctions tested liver enzymes (alanineaminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase [ALP], and gamma-glutamyltransferase [GGT],Hemoglobine (Hb), international normalized ratio (INR). The independent sample t test, Mann Whitney U test, chi-square test andFisher exact test were used. to compare data. P-value of < 0.05 was considered statistically significant.Results: A total 878 patients included in this study. 670 patients had HCC negative (Group A ) 208 had HCC positive(Grup B). Themean age in each group were 57.06 ± 11.27 years in group A and 50.46 ± 13.7 years in group B. (p=0.032). HOMA IR [5.2 (0.6-36)in group A, 4.2 (0.2-85.0) in group B] were lower in group B( p= 0.001). Serum ALP levels [ 184.39 ± 159.72 U/L in Group A, 159.7 2±159.72 U/L in group B] were lower in group B (p = 0.046).Conclusion: Serum Alkaline phosphatase levels can be use as predictive component of the HCC. Follow-up studies are needed.

🔖

Cite This Article

SERİN, A. (2022). Assesment of serum alkaline phosphatase levels on the risk of presence hepatocelluler carcinoma in the liver transplantation patients. Annals of Medical Research, Cilt: 27 - Sayı: 1, 194–198. https://ajindex.com/articles/446204

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Torre LA, Bray F, Siegel R, et al. A. Global cancer statistics, 2012. Cancer J 2015;65:87-108
  2. Tanriverdi O. A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist’s perspective. Med Oncol 2014;31:282
  3. Zhu AX, Chen D, He W, et al. Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma. J Hepatol 2016;65:296-304
  4. Carr BI, Guerra V. Hepatocellular Carcinoma Extrahepatic Metastasis in Relation to Tumor Size and Alkaline Phosphatase Levels. Oncology 2016;90:136- 42
  5. El-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001;5:87-107
  6. Pratt DS, Kaplan MM. Evaluation of abnormal liverenzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-71
  7. Hann HW, Meyers RS, Hann RS, et al. Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients. PLoS one 2012;7:47687 8. Strasak AM, Rapp K, Brant LJ, et al. Association of gamma- glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res 2008,68:3970-7
  8. Kumada T, Toyoda H, Kiriyama S, et al. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values. J Med Virol 2010,82:539-45
  9. Liu X, Meng J, Xu H, et al. Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma. Medicine(Baltimore) 2019;98:15414
  10. Ren M, Juan Li JR. Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis. Medicine(Baltimore) 2019;98:15528
  11. Masuzaki R, Omata M. Screening program in high-risk populations. Hepatocellular Carcinoma 2011:55-68
  12. Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology 2014;59:2188-95
  13. L. Mobarak, D. Omran, M.M. Nabeel, et al. Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease J Med Virol, 2017;89:1062-8
  14. Sahin T, Serin A, Emek E, et al. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis. Transplantation Proceeding September 2019;2397- 402
  15. Yu M Ch, Chan KM, Lee CF, et al. Alkaline Phosphatase: Do